Birchview Capital’s Axogen AXGN Stock Holding History

Birchview Capital’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-119,078	Closed	-$2.12M	–	71
2025 Q3	$2.12M	Sell	119,078 -41,922	-26%	-$608K	1.6%	17
2025 Q2	$1.75M	Hold	161,000	–	–	1.73%	17
2025 Q1	$2.98M	Sell	161,000 -36,000	-18%	-$650K	2.59%	8
2024 Q4	$3.25M	Hold	197,000	–	–	2.64%	9
2024 Q3	$2.76M	Hold	197,000	–	–	2.39%	12
2024 Q2	$1.43M	Buy	197,000 +24,000	+14%	+$164K	1.32%	19
2024 Q1	$1.4M	Hold	173,000	–	–	1.14%	19
2023 Q4	$1.18M	Hold	173,000	–	–	0.92%	23
2023 Q3	$865K	Buy	173,000 +133,000	+333%	+$921K	0.73%	25
2023 Q2	$365K	Buy	+40,000	New	+$373K	0.27%	40
2018 Q4	–	Sell	-10,000	Closed	-$369K	–	53
2018 Q3	$369K	Sell	10,000 -2,000	-17%	-$87.3K	0.24%	42
2018 Q2	$603K	Sell	12,000 -6,000	-33%	-$264K	0.41%	25
2018 Q1	$657K	Sell	18,000 -17,000	-49%	-$521K	0.43%	20
2017 Q4	$991K	Buy	+35,000	New	+$826K	0.58%	15

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Birchview Capital's AXGN Position: Q4 2025 in Review

Birchview Capital sold out of Axogen (AXGN) in Q4 2025, closing a stake of 119,078 shares — an estimated $2.12M sold.

Birchview Capital first reported a position in AXGN in Q4 2017 and held it in 14 quarters. The position peaked at $3.25M in Q4 2024. 208 funds tracked by Wall St. Rank hold AXGN as of Q4 2025.

Birchview Capital reported no remaining Axogen position as of Q4 2025 after selling out during the quarter.
Birchview Capital sold 119,078 Axogen shares in Q4 2025, an estimated $2.12M.
Birchview Capital first reported a position in Axogen in Q4 2017 and held it in 14 quarters.
Birchview Capital's Axogen position peaked at $3.25M in Q4 2024.
208 funds tracked by Wall St. Rank held Axogen as of Q4 2025.

Based on Birchview Capital's 13F filing for Q4 2025, filed 13 Feb 2026.